Impact Biomedical Inc. (IBO)

Name: Impact Biomedical Inc. (IBO) annual fundamentals
Creator: TickerFacts
License: https://creativecommons.org/publicdomain/zero/1.0/

Build a valuation ↗↓ Download CSV

SEC name IMPACT BIOMEDICAL INC. · CIK 0001834105 · NYSE · Pharmaceutical Preparations

Sector Manufacturing
Incorporated NV
Fiscal year ends Dec 31

For the year ended 2025-12-31, Impact Biomedical Inc. reported revenue of $32.0K. Over the twelve months to 2026-06-30, revenue was $35.0K.

Key ratios (year ended 2025-12-31)

n/m

Gross margin (computed)

n/m

Operating margin

n/m

Net margin

-93.9%

Return on year-end equity

Computed by TickerFacts from revenue minus cost of revenue. This may differ from the issuer's reported gross profit or margin; check the revenue and cost definitions.

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: Form 8-K (current report) · 2026-10-09

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. n/a means a matching observation is unavailable. Free cash flow is operating cash flow minus capital expenditures, and EBITDA is operating income plus depreciation and amortization, for the same period, computed by TickerFacts.

The first column covers the twelve months to 2026-06-30 from the latest quarterly report: flows are the last fiscal year plus this year to date minus the same months a year earlier, and balances are as of that date. Per-share figures are annual only.

Period ended	TTM to 2026-06-30	2025-12-31	2024-12-31	2023-12-31	2022-12-31
Revenue	$35.0K	$32.0K	n/a	n/a	$50.0K
Cost of Revenue	n/a	$424.0K	n/a	n/a	n/a
Gross Profit (computed)	n/a	-$392.0K	n/a	n/a	n/a
R&D Expense	$285.0K	$340.0K	$278.0K	$1.69M	$1.23M
Operating Income	-$5.11M	-$4.28M	-$28.75M	-$4.03M	-$3.40M
Depreciation & Amortization	$1.14M	$1.15M	$1.12M	$1.12M	$1.11M
EBITDA	-$3.96M	-$3.14M	-$27.63M	-$2.91M	-$2.29M
Net Income	$791.0K	-$11.84M	-$24.71M	-$4.34M	-$7.25M
EPS (Diluted)	n/a	-$0.38	-$2.30	-$0.07	-$0.10
Total Assets	$16.75M	$17.41M	$20.29M	$44.63M	$46.50M
Total Liabilities	$2.73M	$1.85M	$13.05M	$16.37M	$13.83M
Shareholders' Equity	$10.77M	$12.61M	$4.26M	$25.22M	$29.56M
Cash & Equivalents	n/a	$3.0K	$2.00M	$1.0K	$2.0K
Operating Cash Flow	-$508.0K	-$1.89M	-$2.85M	-$2.85M	-$2.24M
Shares Outstanding	107.82M	104.62M	11.50M	10.00M	70.50M
EPS (Basic)	n/a	-$0.38	-$2.30	-$0.07	-$0.10

Price chart

Chart and quotes by TradingView. Exchange coverage and delays vary.

Open chart on TradingView